<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Dermatol</journal-id><journal-title>BMC Dermatology</journal-title><issn pub-type="epub">1471-5945</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">15601464</article-id><article-id pub-id-type="pmc">545970</article-id><article-id pub-id-type="publisher-id">1471-5945-4-18</article-id><article-id pub-id-type="doi">10.1186/1471-5945-4-18</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A randomized clinical trial comparing hydrocolloid, phenytoin and simple dressings for the treatment of pressure ulcers [ISRCTN33429693]</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Hollisaz</surname><given-names>Mohammad Taghi</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>hollisaz@yahoo.com</email></contrib><contrib id="A2" corresp="yes" contrib-type="author"><name><surname>Khedmat</surname><given-names>Hossein</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>h_khedmat@hotmail.com</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Yari</surname><given-names>Fatemeh</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>yari1672@yahoo.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Rehabilitation, Baqyiatollah Hospital, Baqyiatollah University of Medical Sciences, Tehran, Iran</aff><aff id="I2"><label>2</label>Department of Internal Medicine, Baqyiatollah Hospital, Baqyiatollah University of Medical Sciences, Tehran, Iran</aff><aff id="I3"><label>3</label>Department of Biostatistics, Lorestan University of Medical Sciences, Khoramabad, Iran</aff><pub-date pub-type="collection"><year>2004</year></pub-date><pub-date pub-type="epub"><day>15</day><month>12</month><year>2004</year></pub-date><volume>4</volume><fpage>18</fpage><lpage>18</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-5945/4/18"></ext-link><history><date date-type="received"><day>18</day><month>10</month><year>2003</year></date><date date-type="accepted"><day>15</day><month>12</month><year>2004</year></date></history><permissions><copyright-statement>Copyright © 2004 Hollisaz et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2004</copyright-year><copyright-holder>Hollisaz et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"></ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title><offsets xml_i="3168" xml_f="3178" txt_i="11" txt_f="21">Background</offsets></title><p><offsets xml_i="3189" xml_f="3596" txt_i="22" txt_f="429">Pressure sores are important and common complications of spinal cord injury. Many preventive and therapeutic approaches have been tried and new trials are evolving. One relatively recent method is application of a hydrocolloid dressing (HD). In this study we compared the therapeutic effects of HD on pressure ulcer healing with two other topical applications, phenytoin cream (PC) and simple dressing (SD).</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="3637" xml_f="3644" txt_i="431" txt_f="438">Methods</offsets></title><p><offsets xml_i="3655" xml_f="4149" txt_i="439" txt_f="933">Ninety-one stage I and stage II pressure ulcers of 83 paraplegic male victims of the Iran-Iraq war were randomly allocated to three treatment groups. Mean age and weight of the participants were 36.64 ± 6.04 years and 61.12 ± 5.08 kg, respectively. All the patients were managed in long term care units or in their homes for 8 weeks by a team of general practitioners and nurses, and the ulcer status was recorded as "Complete healing", "Partial healing", "Without improvement" and "Worsening".</offsets></p></sec><sec><title><offsets xml_i="4171" xml_f="4178" txt_i="935" txt_f="942">Results</offsets></title><p><offsets xml_i="4189" xml_f="5396" txt_i="943" txt_f="2126">Complete healing of ulcers, regardless of location and stage, was better in the HD group than the PC [23/31(74.19%) vs 12/30(40%); difference: 34.19%, 95% CI = 10.85–57.52, (P &lt; 0.01)] or the SD [23/31(74.19%) vs 8/30(26.66%); difference: 47.53%, 95% CI = 25.45–69.61, (P &lt; 0.005)] groups. Complete healing of stage I ulcers in the HD group [11/13(85%)] was better than in the SD [5/11(45%); difference: 40%, 95% CI = 4.7–75.22, (P &lt; 0.05)] or PC [2/9 (22%); difference: 63%, 95% CI = 29.69–96.3, (P &lt; 0.005)] groups. Complete healing of stage II ulcer in the HD group [12/18 (67%)] was better than in the SD group [3/19(16%); difference: 51%, 95% CI = 23.73–78.26, (P &lt; 0.005)], but not significantly different from the PC group [10/21 (48%); difference: 19%, 95% CI = -11.47–49.47, (P &gt; 0.05)]. We performed a second analysis considering only one ulcer per patient (i.e. 83 ulcers in 83 patients). This "per patient" analysis showed that complete ulcer healing in the HD group was better than in the PC [20/28(71.4%) vs 11/28 (39.3%); difference: 32.1%, 95% CI = 7.4–56.7, (P &lt; 0.01)] or SD [20/28(71.4%) vs 8/27 (29.6%); difference: 41.8%, 95% CI = 17.7–65.8, (P &lt; 0.005)] groups.</offsets></p></sec><sec><title><offsets xml_i="5418" xml_f="5428" txt_i="2128" txt_f="2138">Conclusion</offsets></title><p><offsets xml_i="5439" xml_f="5568" txt_i="2139" txt_f="2268">We deduced that HD is the most effective method investigated for treating stage I and II pressure ulcers in young paraplegic men.</offsets></p></sec></abstract></article-meta></front><body><sec><title><offsets xml_i="5630" xml_f="5640" txt_i="2277" txt_f="2287">Background</offsets></title><p><offsets xml_i="5651" xml_f="5878" txt_i="2288" txt_f="2515">Skin ulcers caused by pressure and strains are known by various names: decubitus ulcer, bedsore, ischemic ulcer and pressure ulcer. "Pressure ulcer", which indicates the etiology of the lesion, seems the most appropriate name [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="5909" xml_f="5910" txt_i="2515" txt_f="2516">1</offsets></xref><offsets xml_i="5917" xml_f="6178" txt_i="2516" txt_f="2777">]. An estimated 50–80% of individuals suffering from spinal cord injury develop pressure ulcers at least once in their lifetime. Most of these ulcers occur during the first two years after injury, but even after 3–4 years an incidence of 30% has been reported [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="6209" xml_f="6210" txt_i="2777" txt_f="2778">2</offsets></xref><offsets xml_i="6217" xml_f="6218" txt_i="2778" txt_f="2779">-</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="6249" xml_f="6250" txt_i="2779" txt_f="2780">4</offsets></xref><offsets xml_i="6257" xml_f="6259" txt_i="2780" txt_f="2782">].</offsets></p><p><offsets xml_i="6266" xml_f="6335" txt_i="2783" txt_f="2852">Although the major challenge is to prevent the occurrence of ulcers [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="6366" xml_f="6367" txt_i="2852" txt_f="2853">5</offsets></xref><offsets xml_i="6374" xml_f="6375" txt_i="2853" txt_f="2854">,</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="6406" xml_f="6407" txt_i="2854" txt_f="2855">6</offsets></xref><offsets xml_i="6414" xml_f="6544" txt_i="2855" txt_f="2985">], therapeutic measures merit due attention. Pressure ulcer therapy is among the expensive of medical and surgical interventions [</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="6575" xml_f="6576" txt_i="2985" txt_f="2986">5</offsets></xref><offsets xml_i="6583" xml_f="6584" txt_i="2986" txt_f="2987">-</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="6615" xml_f="6616" txt_i="2987" txt_f="2988">7</offsets></xref><offsets xml_i="6623" xml_f="6878" txt_i="2988" txt_f="3243">]. In one study in the United Kingdom, data relating to chronic wound management practice obtained from 15 pressure sore studies showed a cost range of 422–2548 pounds per healed wound for primary dressing, nursing time, wound cleansing and debridements [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="6909" xml_f="6910" txt_i="3243" txt_f="3244">8</offsets></xref><offsets xml_i="6917" xml_f="7089" txt_i="3244" txt_f="3416">]. These figures do not include the much higher costs of hospitalization and plastic surgery. We have tried to find a more effective and cost-efficient method of treatment.</offsets></p><p><offsets xml_i="7096" xml_f="7228" txt_i="3417" txt_f="3549">Different methods have been used for preventing and treating pressure ulcers. These include various training programs for patients [</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="7259" xml_f="7260" txt_i="3549" txt_f="3550">4</offsets></xref><offsets xml_i="7267" xml_f="7268" txt_i="3550" txt_f="3551">,</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="7299" xml_f="7300" txt_i="3551" txt_f="3552">9</offsets></xref><offsets xml_i="7307" xml_f="7308" txt_i="3552" txt_f="3553">,</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="7340" xml_f="7342" txt_i="3553" txt_f="3555">10</offsets></xref><offsets xml_i="7349" xml_f="7441" txt_i="3555" txt_f="3647">]; physiotherapy methods employing ultrasound, ultraviolet irradiation and laser treatment [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="7472" xml_f="7473" txt_i="3647" txt_f="3648">7</offsets></xref><offsets xml_i="7480" xml_f="7729" txt_i="3648" txt_f="3897">]; good nutrition emphasizing high protein, high calorie diet and more liquid; electrical stimulation; and application of local ointments and creams such as bacitracin, silver sulfadiazine, neomycin, polymixin, phenytoin and hydrocolloid dressings [</offsets><xref ref-type="bibr" rid="B11"><offsets xml_i="7761" xml_f="7763" txt_i="3897" txt_f="3899">11</offsets></xref><offsets xml_i="7770" xml_f="7771" txt_i="3899" txt_f="3900">-</offsets><xref ref-type="bibr" rid="B19"><offsets xml_i="7803" xml_f="7805" txt_i="3900" txt_f="3902">19</offsets></xref><offsets xml_i="7812" xml_f="7814" txt_i="3902" txt_f="3904">].</offsets></p><p><offsets xml_i="7821" xml_f="8668" txt_i="3905" txt_f="4752">The results of the studies conducted so far are incompatible, even contradictory. Most of them considered too few patients and/or lacked a control group. In Iran, 5000 patients suffer from spinal cord injury (SCI): of these, 2000 are lran-lraq war victims and 3000 were handicapped by other causes. In view of the enormous prevalence of pressure ulcers in war victims and other spinal handicap patients, and the importance of these lesions in terms of morbidity, mortality and cost of treatment, we have compared the efficacies of applying hydrocolloid dressing, phenytoin cream and a simple dressing. The aims were to determine: 1. which is the most effective in terms of complete ulcer healing; 2. whether healing rates differ with respect to the ulcer stage (I and II) or location (gluteal, ischial, sacral) using these three different methods.</offsets></p></sec><sec sec-type="methods"><title><offsets xml_i="8709" xml_f="8716" txt_i="4754" txt_f="4761">Methods</offsets></title><p><offsets xml_i="8727" xml_f="9004" txt_i="4762" txt_f="5039">The study was a randomized single blind clinical trial involving 2015 Iranian spinal cord injury (SCI) victims of the Iran-Iraq war (1980–1988). The SCI victims were accessed through the mediation and assistance of the Jaonbazan Medical and Engineering Research Center (JMERC) </offsets><ext-link ext-link-type="uri" xlink:href="http://www.jmerc.ac.ir"></ext-link><offsets xml_i="9081" xml_f="9246" txt_i="5039" txt_f="5204">, the medical and research section of the official governmental body responsible for SCI war victims. The study proposal was reviewed, approved and granted by JMERC.</offsets></p><p><offsets xml_i="9253" xml_f="10001" txt_i="5205" txt_f="5953">The medical records of all 2015 subjects were studied to identify cases with pressure ulcers. Where the data were unknown or unreliable, the patients were visited at home or in victims' long term care centers. Finally, 165 pressure ulcers in 151 patients were identified. All relevant data including patient age and weight, the longevity of the ulcer before our intervention, and the size, stage and location of the ulcer, were collected by the general practitioners in the team. Next, all the patients were examined by one of the authors to confirm their eligibility for the study. The eligibility criteria were: A) Inclusion Criteria: 1. Paraplegia caused by spinal cord injury; 2. Pressure ulcer stage I and II according to Shea classification [</offsets><xref ref-type="bibr" rid="B20"><offsets xml_i="10033" xml_f="10035" txt_i="5953" txt_f="5955">20</offsets></xref><offsets xml_i="10042" xml_f="10087" txt_i="5955" txt_f="6000">] or National Pressure Ulcer Advisory Panel [</offsets><xref ref-type="bibr" rid="B21"><offsets xml_i="10119" xml_f="10121" txt_i="6000" txt_f="6002">21</offsets></xref><offsets xml_i="10128" xml_f="10136" txt_i="6002" txt_f="6010">] (Fig. </offsets><xref ref-type="fig" rid="F1"><offsets xml_i="10166" xml_f="10167" txt_i="6010" txt_f="6011">1</offsets></xref><offsets xml_i="10174" xml_f="10515" txt_i="6011" txt_f="6352">); 3. Patient's informed consent; 4. Smoothness of ulcer area to establish whether adhesive could be used at the site. Exclusion criteria: 1. Addiction; 2. Heavy smoking (more than 20 cigarettes a day or more than 10 packs per year; 3. Concomitant chronic disease (e.g. diabetes mellitus or frank vascular disease such as Buerger's disease).</offsets></p><fig position="float" id="F1"><label><offsets xml_i="10556" xml_f="10564" txt_i="6353" txt_f="6361">Figure 1</offsets></label><caption><p><offsets xml_i="10584" xml_f="10619" txt_i="6361" txt_f="6396">Two pressure ulcer classifications.</offsets></p></caption><graphic xlink:href="1471-5945-4-18-1"></graphic></fig><p><offsets xml_i="10691" xml_f="11089" txt_i="6397" txt_f="6795">Seventy-four ulcers in 68 patients were excluded because they did not meet these eligibility criteria: 31 ulcers (28 patients) were stage III or higher; 27 ulcers (25 patients) were excluded because of patient's smoking/addiction; 5 ulcers (5 patients) had uneven surfaces; 4 ulcers (4 patients) were excluded because of systemic diseases; and 6 patients with 7 ulcers refused to participate (Fig. </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="11119" xml_f="11120" txt_i="6795" txt_f="6796">2</offsets></xref><offsets xml_i="11127" xml_f="11586" txt_i="6796" txt_f="7255">). Thus, the study sample comprised 83 patients with 91 pressure ulcers in the ischial, sacral or gluteal areas. These 91 ulcers were allocated to three different groups (30 ulcers each) by stratified randomization. Three therapeutic methods were applied as follow: simple dressing (SD), hydrocolloid dressing (HD), and adhesive and phenytoin cream (PC). Two general practitioners and nine nurses trained in treatment interventions administered the protocols.</offsets></p><fig position="float" id="F2"><label><offsets xml_i="11627" xml_f="11635" txt_i="7256" txt_f="7264">Figure 2</offsets></label><caption><p><offsets xml_i="11655" xml_f="11716" txt_i="7264" txt_f="7325">Flow diagram of participants through each stage of the study.</offsets></p></caption><graphic xlink:href="1471-5945-4-18-2"></graphic></fig><p><offsets xml_i="11788" xml_f="12293" txt_i="7326" txt_f="7831">The SD patients were visited twice a day, the PC patients once a day and the HD patients twice a week. All participants were visited and examined in their family homes or nursing homes by general practitioners every two weeks to ensure that the treatments were being properly applied and were consistent among the three groups. There were no differences in the facilities available for patients in family homes versus nursing homes, and all the patients had free access to victims' long term care centers.</offsets></p><p><offsets xml_i="12300" xml_f="13474" txt_i="7832" txt_f="9006">In the SD group, the following steps were taken twice a day. The ulcer was cleaned and washed 3 times with normal saline, then dried with a sterile gauze and, depending on the size of ulcer, covered with wet saline gauze dressing. In the PC group, daily dressing and cleaning of ulcer were similar to the SD group, except that a thin layer of phenytoin cream was applied to the ulcer before the dressing was performed. In the HD group, after the ulcer had been cleaned in a similar manner to the SD group, the hydrocolloid adhesive dressing was applied to the ulcer area. The adhesive dressings were changed twice a week. Any necrotic tissue was debrided before treatment; all debridements preceded ulcer tracing and assignment of the participants to the trial groups. No debridement was allowed after treatment had started. No concomitant topical or systemic antibiotic, glucocorticoid or immunosuppressive agent was allowed during the treatment period. Fortunately, none of our patients needed debridement or the aforementioned concomitant therapies during the study period. There were no differences among the trial groups with respect to other concomitant care measures.</offsets></p><p><offsets xml_i="13481" xml_f="13956" txt_i="9007" txt_f="9482">Every two weeks a questionnaire regarding the ulcer's status was completed by the general practitioners; and at the end of 8 weeks, the ulcers' conditions were examined blind by one author and assessed as "Complete Healing", "Partial Healing", "Without Improvement" or "Worsening". To measure each ulcer's surface area, the ulcer borders were traced on to a paper overlay. This primary schematic representation was then scanned, redrawn and measured by AutoCAD 2000 software.</offsets></p><p><offsets xml_i="13963" xml_f="14672" txt_i="9483" txt_f="10192">The primary outcome was whether or not the ulcer was completely healed within 8 weeks. "Complete ulcer healing" was defined as: A) For stage I ulcer, intact epidermis, no red area; B) For stage II ulcers, intact dermis and epidermis, no abrasion or ulceration. Other definitions were as follows. "Partial healing" = any decrease in ulcer size compared to the baseline ulcer tracing, excluding complete healing. "Without improvement" = no change in ulcer size compared to the baseline ulcer tracing. "Worsening" = any increase in ulcer size compared to the baseline ulcer tracing. The difference in responses between patients receiving HD and patients receiving the other therapies (PC or SD) were determined [</offsets><xref ref-type="bibr" rid="B22"><offsets xml_i="14704" xml_f="14706" txt_i="10192" txt_f="10194">22</offsets></xref><offsets xml_i="14713" xml_f="14715" txt_i="10194" txt_f="10196">].</offsets></p><p><offsets xml_i="14722" xml_f="15076" txt_i="10197" txt_f="10551">Before the study, we assumed response rates of 30%, 40% and 80% for SD, PC and HD, respectively. Thus, based on the 40% difference, power of 0.85, 95% confidence level and estimated follow-up loss of 10%, 29 patients were required for each study group. The number of ulcers that met the eligibility criteria totaled 91 and all were enrolled in the study.</offsets></p><p><offsets xml_i="15083" xml_f="15617" txt_i="10552" txt_f="11086">A random-number table was used to generate the random allocation sequence, and stratified randomization was used to achieve balance between the treatment groups and subgroups (ulcer stages and locations). If a patient had more than one ulcer, all the ulcers were treated by the same method to eliminate the possible complicating factor of treatment interactions. The statistician in the team generated the random allocation sequence. He was informed of the patient list (numbers only) and the ulcer stage and location of each patient.</offsets></p><p><offsets xml_i="15624" xml_f="16117" txt_i="11087" txt_f="11580">The treatment category for each patient was determined by the statistician and was delivered in an opaque sealed envelope bearing only the number of the patient. These sealed envelopes were delivered to the general practitioners, along with the list of patients' numbers and names. After each patient was visited, the appropriately numbered envelope was opened by the general practitioner to determine whether the SD, PC or HD method would be used, then the appropriate intervention commenced.</offsets></p><p><offsets xml_i="16124" xml_f="16870" txt_i="11581" txt_f="12327">The authors were blind to the patients' assignment to trial groups. The general practitioners were also blind to the treatment of each patient up to the start of the study, when they opened the sealed envelopes. After intervention began, both the general practitioners and the nurses knew the trial groups, because significant differences among the three treatment methods precluded blinding. The patients were also aware of the treatment methods, although they initially had equal chances of entering any of the trial groups. Thus, the study was single-blinded and the author who enrolled the patients to the study was blind to treatment assignment. The author who finally assessed the outcomes was also blind to the trial group of each patient.</offsets></p><p><offsets xml_i="16877" xml_f="17659" txt_i="12328" txt_f="13107">To maintain the blinded status on assessment of outcomes, the assessor examined the patients, after the ulcer dressings had been removed by the general practitioners, with no knowledge of the trial groups to which they had been assigned. The gross appearance of the ulcers without dressing, whether healed or not, did not indicate the trial group. The assessor was asked during the 8-week outcome assessment to try to identify which treatment has been administered to each patient. Overall, 27.7% of his guesses were correct (25% in the HD group, 32.1% in the PC group and 25.9% in the SD group), so they were were no better than chance; i.e. there were no significant differences among the three trial groups with respect to proportions guessed correctly (P &gt; 0.2 in all cases).</offsets></p><p><offsets xml_i="17666" xml_f="18345" txt_i="13108" txt_f="13784">The study proposal was designed in November 2001, and the recruitment of patients began in March 2002 and lasted about 2 months. Then the patients were allocated to the treatment groups and followed-up for another 2 months. Finally, all the collected data were analyzed within 2 months. Thus the study from proposal to final analysis took about 10 months (November 2001-September 2002). At the end of the study, all the data collected from the patients' preliminary and complementary questionnaires were analyzed by SPSS software using ANOVA and Chi square tests, and P-values of &lt;0.05 were assumed significant. The 95% confidence intervals were also calculated and reported [</offsets><xref ref-type="bibr" rid="B23"><offsets xml_i="18377" xml_f="18379" txt_i="13784" txt_f="13786">23</offsets></xref><offsets xml_i="18386" xml_f="18613" txt_i="13786" txt_f="14013">]. For rare events (more than 20 percent of cross tabulation cells had values less than 5), Fisher's exact test was used. Based on stage and location of ulcers, subgroup analyses were performed using the same statistical tests.</offsets></p></sec><sec><title><offsets xml_i="18635" xml_f="18642" txt_i="14015" txt_f="14022">Results</offsets></title><p><offsets xml_i="18653" xml_f="19018" txt_i="14023" txt_f="14388">Ninety-one ulcers in 83 male patients were treated by one of three methods. The mean age and weight of the patients were 36.64 ± 6.04 years and 61.12 ± 5.08 kg, respectively. Of the 91 ulcers, 33 were stage I and the remaining 58 were stage II. There were no significant differences among the three therapeutic groups in baseline demographic characteristics (table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="19050" xml_f="19051" txt_i="14388" txt_f="14389">1</offsets></xref><offsets xml_i="19058" xml_f="19133" txt_i="14389" txt_f="14464">) or in ulcer location (sacral, gluteal, ischial) or stage (I or II) (Fig. </offsets><xref ref-type="fig" rid="F3"><offsets xml_i="19163" xml_f="19164" txt_i="14464" txt_f="14465">3</offsets></xref><offsets xml_i="19171" xml_f="19176" txt_i="14465" txt_f="14470"> and </offsets><xref ref-type="fig" rid="F4"><offsets xml_i="19206" xml_f="19207" txt_i="14470" txt_f="14471">4</offsets></xref><offsets xml_i="19214" xml_f="19216" txt_i="14471" txt_f="14473">).</offsets></p><table-wrap position="float" id="T1"><label><offsets xml_i="19264" xml_f="19271" txt_i="14474" txt_f="14481">Table 1</offsets></label><caption><p><offsets xml_i="19291" xml_f="19396" txt_i="14481" txt_f="14586">Baseline characteristics of study subjects assigned to hydrocolloid, phenytoin and simple dressing groups</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="right"><bold><offsets xml_i="19482" xml_f="19491" txt_i="14587" txt_f="14596">Variables</offsets></bold></td><td align="left"><bold><offsets xml_i="19526" xml_f="19556" txt_i="14597" txt_f="14627">Mean Age Of patients (yr ± SD)</offsets></bold></td><td align="left"><bold><offsets xml_i="19591" xml_f="19624" txt_i="14628" txt_f="14661">Mean weight Of patients (kg ± SD)</offsets></bold></td><td align="left"><bold><offsets xml_i="19659" xml_f="19708" txt_i="14662" txt_f="14711">Mean duration of ulcer before treatment (wk ± SD)</offsets></bold></td><td align="left"><bold><offsets xml_i="19743" xml_f="19762" txt_i="14712" txt_f="14731">Mean ulcer size (cm</offsets><sup><offsets xml_i="19767" xml_f="19769" txt_i="14731" txt_f="14733">2 </offsets></sup><offsets xml_i="19775" xml_f="19780" txt_i="14733" txt_f="14738">± SD)</offsets></bold></td><td align="center" colspan="2"><bold><offsets xml_i="19829" xml_f="19848" txt_i="14739" txt_f="14758">Stage of ulcer (no)</offsets></bold></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td colspan="2"><hr></hr></td></tr><tr><td align="left"><bold><offsets xml_i="19976" xml_f="19995" txt_i="14765" txt_f="14784">Treatment group; no</offsets></bold></td><td></td><td></td><td></td><td></td><td align="center"><bold><offsets xml_i="20068" xml_f="20069" txt_i="14789" txt_f="14790">I</offsets></bold></td><td align="center"><bold><offsets xml_i="20106" xml_f="20108" txt_i="14791" txt_f="14793">II</offsets></bold></td></tr></thead><tbody><tr><td align="left"><bold><offsets xml_i="20167" xml_f="20198" txt_i="14794" txt_f="14825">Total n = 83 patients 91 ulcers</offsets></bold></td><td align="left"><offsets xml_i="20227" xml_f="20239" txt_i="14826" txt_f="14838">36.64 ± 6.04</offsets></td><td align="left"><offsets xml_i="20261" xml_f="20273" txt_i="14839" txt_f="14851">61.12 ± 5.08</offsets></td><td align="left"><offsets xml_i="20295" xml_f="20306" txt_i="14852" txt_f="14863">6.25 ± 6.56</offsets></td><td align="left"><offsets xml_i="20328" xml_f="20340" txt_i="14864" txt_f="14876">7.54 ± 12.99</offsets></td><td align="left"><offsets xml_i="20362" xml_f="20364" txt_i="14877" txt_f="14879">33</offsets></td><td align="left"><offsets xml_i="20386" xml_f="20388" txt_i="14880" txt_f="14882">58</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="20425" xml_f="20463" txt_i="14883" txt_f="14921">Hydrocolloid n = 28 patients 31 ulcers</offsets></bold></td><td align="left"><offsets xml_i="20492" xml_f="20504" txt_i="14922" txt_f="14934">36.81 ± 6.71</offsets></td><td align="left"><offsets xml_i="20526" xml_f="20538" txt_i="14935" txt_f="14947">62.26 ± 5.44</offsets></td><td align="left"><offsets xml_i="20560" xml_f="20571" txt_i="14948" txt_f="14959">7.63 ± 5.59</offsets></td><td align="left"><offsets xml_i="20593" xml_f="20604" txt_i="14960" txt_f="14971">7.26 ± 15.4</offsets></td><td align="left"><offsets xml_i="20626" xml_f="20628" txt_i="14972" txt_f="14974">13</offsets></td><td align="left"><offsets xml_i="20650" xml_f="20652" txt_i="14975" txt_f="14977">18</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="20689" xml_f="20724" txt_i="14978" txt_f="15013">Phenytoin n = 28 patients 30 ulcers</offsets></bold></td><td align="left"><offsets xml_i="20753" xml_f="20764" txt_i="15014" txt_f="15025">36.5 ± 4.99</offsets></td><td align="left"><offsets xml_i="20786" xml_f="20798" txt_i="15026" txt_f="15038">60.07 ± 4.39</offsets></td><td align="left"><offsets xml_i="20820" xml_f="20831" txt_i="15039" txt_f="15050">5.84 ± 8.04</offsets></td><td align="left"><offsets xml_i="20853" xml_f="20864" txt_i="15051" txt_f="15062">5.12 ± 3.63</offsets></td><td align="left"><offsets xml_i="20886" xml_f="20887" txt_i="15063" txt_f="15064">9</offsets></td><td align="left"><offsets xml_i="20909" xml_f="20911" txt_i="15065" txt_f="15067">21</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="20948" xml_f="20989" txt_i="15068" txt_f="15109">Simple dressing n = 27 patients 30 ulcers</offsets></bold></td><td align="left"><offsets xml_i="21018" xml_f="21029" txt_i="15110" txt_f="15121">36.6 ± 6.17</offsets></td><td align="left"><offsets xml_i="21051" xml_f="21060" txt_i="15122" txt_f="15131">61 ± 5.03</offsets></td><td align="left"><offsets xml_i="21082" xml_f="21093" txt_i="15132" txt_f="15143">5.25 ± 5.39</offsets></td><td align="left"><offsets xml_i="21115" xml_f="21128" txt_i="15144" txt_f="15157">10.27 ± 15.32</offsets></td><td align="left"><offsets xml_i="21150" xml_f="21152" txt_i="15158" txt_f="15160">11</offsets></td><td align="left"><offsets xml_i="21174" xml_f="21176" txt_i="15161" txt_f="15163">19</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="21213" xml_f="21255" txt_i="15164" txt_f="15206">P-Value of comparing variables of 3 groups</offsets></bold></td><td align="left"><offsets xml_i="21284" xml_f="21295" txt_i="15207" txt_f="15215">P &gt; 0.10</offsets></td><td align="left"><offsets xml_i="21317" xml_f="21328" txt_i="15216" txt_f="15224">P &gt; 0.10</offsets></td><td align="left"><offsets xml_i="21350" xml_f="21361" txt_i="15225" txt_f="15233">P &gt; 0.10</offsets></td><td align="left"><offsets xml_i="21383" xml_f="21394" txt_i="15234" txt_f="15242">P &gt; 0.10</offsets></td><td align="left" colspan="2"><offsets xml_i="21428" xml_f="21439" txt_i="15243" txt_f="15251">P &gt; 0.62</offsets></td></tr></tbody></table></table-wrap><fig position="float" id="F3"><label><offsets xml_i="21515" xml_f="21523" txt_i="15252" txt_f="15260">Figure 3</offsets></label><caption><p><offsets xml_i="21543" xml_f="21604" txt_i="15260" txt_f="15321">Ulcer distribution according to treatment group and location.</offsets></p></caption><graphic xlink:href="1471-5945-4-18-3"></graphic></fig><fig position="float" id="F4"><label><offsets xml_i="21710" xml_f="21718" txt_i="15322" txt_f="15330">Figure 4</offsets></label><caption><p><offsets xml_i="21738" xml_f="21796" txt_i="15330" txt_f="15388">Ulcer distribution according to treatment group and stage.</offsets></p></caption><graphic xlink:href="1471-5945-4-18-4"></graphic></fig><p><offsets xml_i="21868" xml_f="21971" txt_i="15389" txt_f="15492">The numbers of ulcers and the degree of improvement in the three therapeutic groups are shown in table </offsets><xref ref-type="table" rid="T2"><offsets xml_i="22003" xml_f="22004" txt_i="15492" txt_f="15493">2</offsets></xref><offsets xml_i="22011" xml_f="22839" txt_i="15493" txt_f="16303">. The completion of healing, regardless of location and stage, was better in the HD than in the PC [23/31(74.19%) vs 12/30(40%); difference 34.19%, 95% CI = 10.85–57.52, (P &lt; 0.01)] or the SD [23/31(74.19%) vs 8/30(26.66%); difference 47.53%, 95% CI = 25.45–69.61, (P &lt; 0.005)] groups. Completion of healing of stage I ulcers in the HD group [11/13(85%)] was also better than in the SD [5/11(45%); difference 40%, 95% CI = 4.7–75.22, (P &lt; 0.05)] or PC [2/9 (22%); difference 63%, 95% CI = 29.69–96.3, (P &lt; 0.005)] groups. Completion of healing of stage II ulcers was better in the HD group [12/18(67%)] than in the SD group [3/19(16%); difference 51%, 95% CI = 23.73–78.26, (P &lt; 0.005)], but there was no significant difference from the PC group [10/21 (48%); difference 19%, 95 CI = -11.47–49.47, (P &gt; 0.05)].</offsets></p><table-wrap position="float" id="T2"><label><offsets xml_i="22887" xml_f="22894" txt_i="16304" txt_f="16311">Table 2</offsets></label><caption><p><offsets xml_i="22914" xml_f="23015" txt_i="16311" txt_f="16412">Healing status of pressure ulcers in 3 treatment groups (hydrocolloid, phenytoin and simple dressing)</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="right"><bold><offsets xml_i="23101" xml_f="23115" txt_i="16413" txt_f="16427">healing status</offsets></bold></td><td align="center"><bold><offsets xml_i="23152" xml_f="23160" txt_i="16428" txt_f="16436">Complete</offsets></bold></td><td align="center"><bold><offsets xml_i="23197" xml_f="23204" txt_i="16437" txt_f="16444">Partial</offsets></bold></td><td align="center"><bold><offsets xml_i="23241" xml_f="23253" txt_i="16445" txt_f="16457">Not improved</offsets></bold></td><td align="center"><bold><offsets xml_i="23290" xml_f="23298" txt_i="16458" txt_f="16466">Worsened</offsets></bold></td><td align="center"><bold><offsets xml_i="23335" xml_f="23340" txt_i="16467" txt_f="16472">Total</offsets></bold></td></tr><tr><td align="left"><bold><offsets xml_i="23384" xml_f="23407" txt_i="16473" txt_f="16496">Treatment group; no (%)</offsets></bold></td><td></td><td></td><td></td><td></td><td></td></tr></thead><tbody><tr><td align="left"><bold><offsets xml_i="23511" xml_f="23530" txt_i="16502" txt_f="16521">Hydrocolloid n = 31</offsets></bold></td><td align="center"><offsets xml_i="23561" xml_f="23572" txt_i="16522" txt_f="16533">23 (74.19%)</offsets></td><td align="center"><offsets xml_i="23596" xml_f="23606" txt_i="16534" txt_f="16544">4 (12.58%)</offsets></td><td align="center"><offsets xml_i="23630" xml_f="23639" txt_i="16545" txt_f="16554">2 (6.45%)</offsets></td><td align="center"><offsets xml_i="23663" xml_f="23672" txt_i="16555" txt_f="16564">2 (6.45%)</offsets></td><td align="center"><offsets xml_i="23696" xml_f="23705" txt_i="16565" txt_f="16574">31 (100%)</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="23742" xml_f="23758" txt_i="16575" txt_f="16591">Phenytoin n = 30</offsets></bold></td><td align="center"><offsets xml_i="23789" xml_f="23797" txt_i="16592" txt_f="16600">12 (40%)</offsets></td><td align="center"><offsets xml_i="23821" xml_f="23831" txt_i="16601" txt_f="16611">4 (13.33%)</offsets></td><td align="center"><offsets xml_i="23855" xml_f="23863" txt_i="16612" txt_f="16620">12 (40%)</offsets></td><td align="center"><offsets xml_i="23887" xml_f="23896" txt_i="16621" txt_f="16630">2 (6.66%)</offsets></td><td align="center"><offsets xml_i="23920" xml_f="23929" txt_i="16631" txt_f="16640">30 (100%)</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="23966" xml_f="23988" txt_i="16641" txt_f="16663">Simple dressing n = 30</offsets></bold></td><td align="center"><offsets xml_i="24019" xml_f="24029" txt_i="16664" txt_f="16674">8 (26.66%)</offsets></td><td align="center"><offsets xml_i="24053" xml_f="24063" txt_i="16675" txt_f="16685">5 (16.66%)</offsets></td><td align="center"><offsets xml_i="24087" xml_f="24097" txt_i="16686" txt_f="16696">8 (26.66%)</offsets></td><td align="center"><offsets xml_i="24121" xml_f="24128" txt_i="16697" txt_f="16704">9 (30%)</offsets></td><td align="center"><offsets xml_i="24152" xml_f="24161" txt_i="16705" txt_f="16714">30 (100%)</offsets></td></tr></tbody></table></table-wrap><p><offsets xml_i="24203" xml_f="24987" txt_i="16715" txt_f="17481">Gluteal ulcers healed more completely in the HD group [6/6(100%)] than in the PC [2/7 (29%); difference 71%, 95% CI = 37.38–100, (P &lt; 0.005)] or SD [1/8(13%); difference 87%, 95% CI = 63.69–100, (P &lt; 0.001)] groups. The corresponding figures for ischial ulcers were: HD group 13/18(72%) and SD group 3/14 (21%); difference 51%, 95% CI = 21.2–80.7, (P &lt; 0.005)]. The PC group was not significantly different from HD: 8/18(44%); difference 28%, 95% CI = -2.9–58.9, (P &lt; 0.1)]. In the case of sacral ulcers, complete healing in HD group did not differ significantly from either of the others. The results were: HD group 4/7 (57%), SD group 4/8(50%); difference 7%, 95% CI = -50–64.15, (P &gt; 0.35), and PC group 2/5(40%); difference 17%, 95% CI = -39.4–73.4, (P &gt; 0.20)].</offsets></p><p><offsets xml_i="24994" xml_f="25301" txt_i="17482" txt_f="17789">We performed a second analysis on 83 ulcers in 83 patients. We selected one ulcer per patient using a random number table; 31 of the 83 ulcers were stage I and the remaining 52 were stage II. There were again no significant differences among the trial groups with respect to baseline characteristics (table </offsets><xref ref-type="table" rid="T3"><offsets xml_i="25333" xml_f="25334" txt_i="17789" txt_f="17790">3</offsets></xref><offsets xml_i="25341" xml_f="25744" txt_i="17790" txt_f="18187">). This "per patient" analysis showed that complete ulcer healing, regardless of location and stage, in the HD group was better than in the PC [20/28(71.4%, 95% CI = 54.7–88.1) vs 11/28 (39.3%, 95% CI:21.3–57.3); difference 32.1%, 95% CI = 7.4–56.7, (P &lt; 0.01)] or SD [20/28(71.4%, 95% CI = 54.7–88.1) vs 8/27 (29.6%, 95% CI = 12.4–46.8); difference 41.8%, 95% CI = 17.7–65.8, (P &lt; 0.005)] groups.</offsets></p><table-wrap position="float" id="T3"><label><offsets xml_i="25792" xml_f="25799" txt_i="18188" txt_f="18195">Table 3</offsets></label><caption><p><offsets xml_i="25819" xml_f="25960" txt_i="18195" txt_f="18336">Baseline characteristics of study subjects assigned to three trial groups considering the patient as unit of analysis(one ulcer per patient).</offsets></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="right"><bold><offsets xml_i="26046" xml_f="26055" txt_i="18337" txt_f="18346">Variables</offsets></bold></td><td align="center"><bold><offsets xml_i="26092" xml_f="26141" txt_i="18347" txt_f="18396">Mean duration of ulcer before treatment (wk ± SD)</offsets></bold></td><td align="center"><bold><offsets xml_i="26178" xml_f="26197" txt_i="18397" txt_f="18416">Mean ulcer size (cm</offsets><sup><offsets xml_i="26202" xml_f="26204" txt_i="18416" txt_f="18418">2 </offsets></sup><offsets xml_i="26210" xml_f="26215" txt_i="18418" txt_f="18423">± SD)</offsets></bold></td><td align="center" colspan="2"><bold><offsets xml_i="26264" xml_f="26283" txt_i="18424" txt_f="18443">Stage of ulcer (no)</offsets></bold></td></tr><tr><td></td><td></td><td></td><td colspan="2"><hr></hr></td></tr><tr><td align="left"><bold><offsets xml_i="26393" xml_f="26412" txt_i="18448" txt_f="18467">Treatment group; no</offsets></bold></td><td></td><td></td><td align="center"><bold><offsets xml_i="26467" xml_f="26468" txt_i="18470" txt_f="18471">I</offsets></bold></td><td align="center"><bold><offsets xml_i="26505" xml_f="26507" txt_i="18472" txt_f="18474">II</offsets></bold></td></tr></thead><tbody><tr><td align="left"><bold><offsets xml_i="26566" xml_f="26578" txt_i="18475" txt_f="18487">Total n = 83</offsets></bold></td><td align="center"><offsets xml_i="26609" xml_f="26620" txt_i="18488" txt_f="18499">5.92 ± 6.27</offsets></td><td align="center"><offsets xml_i="26644" xml_f="26656" txt_i="18500" txt_f="18512">7.78 ± 13.53</offsets></td><td align="center"><offsets xml_i="26680" xml_f="26682" txt_i="18513" txt_f="18515">31</offsets></td><td align="center"><offsets xml_i="26706" xml_f="26708" txt_i="18516" txt_f="18518">52</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="26745" xml_f="26764" txt_i="18519" txt_f="18538">Hydrocolloid n = 28</offsets></bold></td><td align="center"><offsets xml_i="26795" xml_f="26806" txt_i="18539" txt_f="18550">7.12 ± 5.68</offsets></td><td align="center"><offsets xml_i="26830" xml_f="26841" txt_i="18551" txt_f="18562">7.47 ± 16.4</offsets></td><td align="center"><offsets xml_i="26865" xml_f="26867" txt_i="18563" txt_f="18565">12</offsets></td><td align="center"><offsets xml_i="26891" xml_f="26893" txt_i="18566" txt_f="18568">16</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="26930" xml_f="26946" txt_i="18569" txt_f="18585">Phenytoin n = 28</offsets></bold></td><td align="center"><offsets xml_i="26977" xml_f="26987" txt_i="18586" txt_f="18596">6.11 ± 8.4</offsets></td><td align="center"><offsets xml_i="27011" xml_f="27022" txt_i="18597" txt_f="18608">5.13 ± 3.67</offsets></td><td align="center"><offsets xml_i="27046" xml_f="27047" txt_i="18609" txt_f="18610">9</offsets></td><td align="center"><offsets xml_i="27071" xml_f="27073" txt_i="18611" txt_f="18613">19</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="27110" xml_f="27132" txt_i="18614" txt_f="18636">Simple dressing n = 27</offsets></bold></td><td align="center"><offsets xml_i="27163" xml_f="27174" txt_i="18637" txt_f="18648">4.47 ± 3.64</offsets></td><td align="center"><offsets xml_i="27198" xml_f="27211" txt_i="18649" txt_f="18662">10.84 ± 16.32</offsets></td><td align="center"><offsets xml_i="27235" xml_f="27237" txt_i="18663" txt_f="18665">10</offsets></td><td align="center"><offsets xml_i="27261" xml_f="27263" txt_i="18666" txt_f="18668">17</offsets></td></tr><tr><td align="left"><bold><offsets xml_i="27300" xml_f="27307" txt_i="18669" txt_f="18676">P-Value</offsets></bold></td><td align="center"><offsets xml_i="27338" xml_f="27349" txt_i="18677" txt_f="18685">P &gt; 0.20</offsets></td><td align="center"><offsets xml_i="27373" xml_f="27384" txt_i="18686" txt_f="18694">P &gt; 0.20</offsets></td><td align="center" colspan="2"><offsets xml_i="27420" xml_f="27431" txt_i="18695" txt_f="18703">P &gt; 0.70</offsets></td></tr></tbody></table></table-wrap><p><offsets xml_i="27473" xml_f="27758" txt_i="18704" txt_f="18989">All completely healed ulcer patients were followed up by monthly visits from general practitioners for a further 4 months after the end of the trial. They were also examined by the assessor author. No recurrence of ulceration was observed in any of the trial groups during this period.</offsets></p><p><offsets xml_i="27765" xml_f="27920" txt_i="18990" txt_f="19145">All patients completed the study and there were no losses to follow up, no treatment withdrawals, no trial group changes and no major adverse events (Fig. </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="27950" xml_f="27951" txt_i="19145" txt_f="19146">2</offsets></xref><offsets xml_i="27958" xml_f="27960" txt_i="19146" txt_f="19148">).</offsets></p></sec><sec><title><offsets xml_i="27982" xml_f="27992" txt_i="19150" txt_f="19160">Discussion</offsets></title><p><offsets xml_i="28003" xml_f="28162" txt_i="19161" txt_f="19320">Diphenyl hydantoin sodium (phenytoin) is an effective anti-epileptic medication. Its capacity to accelerate ulcer healing was reported more than 40 years ago [</offsets><xref ref-type="bibr" rid="B24"><offsets xml_i="28194" xml_f="28196" txt_i="19320" txt_f="19322">24</offsets></xref><offsets xml_i="28203" xml_f="28405" txt_i="19322" txt_f="19524">]. Since then, it has been used topically for different kinds of wounds and ulcers such as war wounds, sores caused by venous stasis, atrophic ulcers and burns, and positive effects have been reported [</offsets><xref ref-type="bibr" rid="B25"><offsets xml_i="28437" xml_f="28439" txt_i="19524" txt_f="19526">25</offsets></xref><offsets xml_i="28446" xml_f="28447" txt_i="19526" txt_f="19527">-</offsets><xref ref-type="bibr" rid="B27"><offsets xml_i="28479" xml_f="28481" txt_i="19527" txt_f="19529">27</offsets></xref><offsets xml_i="28488" xml_f="28744" txt_i="19529" txt_f="19785">]. Possible mechanisms of action of phenytoin cream on wound healing are as follows: 1. Decrease in serum corticosteroid; 2. Acceleration of assembly and presence of collagen and fibrin in the ulcer area, and stimulation of alkaline phosphatase secretion [</offsets><xref ref-type="bibr" rid="B28"><offsets xml_i="28776" xml_f="28778" txt_i="19785" txt_f="19787">28</offsets></xref><offsets xml_i="28785" xml_f="28787" txt_i="19787" txt_f="19789">].</offsets></p><p><offsets xml_i="28794" xml_f="29097" txt_i="19790" txt_f="20093">The use of HD for healing pressure ulcers dates from about 20 years ago. The benefits of this method in comparison with conventional methods include reduction of bacterial contamination, facilitation of patient movement, improvement in patient's psychological condition, more convenience and less pain [</offsets><xref ref-type="bibr" rid="B29"><offsets xml_i="29129" xml_f="29131" txt_i="20093" txt_f="20095">29</offsets></xref><offsets xml_i="29138" xml_f="29139" txt_i="20095" txt_f="20096">-</offsets><xref ref-type="bibr" rid="B34"><offsets xml_i="29171" xml_f="29173" txt_i="20096" txt_f="20098">34</offsets></xref><offsets xml_i="29180" xml_f="29379" txt_i="20098" txt_f="20297">]. Hydrocolloid adhesive dressings absorb water and low molecular weight components from ulcer secretions, so they swell to produce a jelly. This jelly protects the ulcer, and new cells proliferate [</offsets><xref ref-type="bibr" rid="B35"><offsets xml_i="29411" xml_f="29413" txt_i="20297" txt_f="20299">35</offsets></xref><offsets xml_i="29420" xml_f="29545" txt_i="20299" txt_f="20424">]. Moreover, the jelly stimulates the immune system locally by activating granulocytes, monocytes and the complement system [</offsets><xref ref-type="bibr" rid="B36"><offsets xml_i="29577" xml_f="29579" txt_i="20424" txt_f="20426">36</offsets></xref><offsets xml_i="29586" xml_f="29681" txt_i="20426" txt_f="20521">], decreasing the effects of bacterial colonization and ensuring autodebridement of the ulcer [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="29712" xml_f="29713" txt_i="20521" txt_f="20522">1</offsets></xref><offsets xml_i="29720" xml_f="29722" txt_i="20522" txt_f="20524">].</offsets></p><p><offsets xml_i="29729" xml_f="30061" txt_i="20525" txt_f="20857">Bacterial colonization is likely under the HD layer and is responsible for the unpleasant aroma detected when the dressings are changed, but it should not be misinterpreted as clinical infection. In fact, clinical trials of HD on more than 2000 ulcers have shown a much lower incidence of infection than in other treatment methods [</offsets><xref ref-type="bibr" rid="B29"><offsets xml_i="30093" xml_f="30095" txt_i="20857" txt_f="20859">29</offsets></xref><offsets xml_i="30102" xml_f="30103" txt_i="20859" txt_f="20860">,</offsets><xref ref-type="bibr" rid="B30"><offsets xml_i="30135" xml_f="30137" txt_i="20860" txt_f="20862">30</offsets></xref><offsets xml_i="30144" xml_f="30145" txt_i="20862" txt_f="20863">,</offsets><xref ref-type="bibr" rid="B33"><offsets xml_i="30177" xml_f="30179" txt_i="20863" txt_f="20865">33</offsets></xref><offsets xml_i="30186" xml_f="30321" txt_i="20865" txt_f="21000">]. Thus, the ulcer dry-out method is not considered as useful as it once was, and the current trend is towards a damp method using HD [</offsets><xref ref-type="bibr" rid="B37"><offsets xml_i="30353" xml_f="30355" txt_i="21000" txt_f="21002">37</offsets></xref><offsets xml_i="30362" xml_f="30363" txt_i="21002" txt_f="21003">-</offsets><xref ref-type="bibr" rid="B41"><offsets xml_i="30395" xml_f="30397" txt_i="21003" txt_f="21005">41</offsets></xref><offsets xml_i="30404" xml_f="30406" txt_i="21005" txt_f="21007">].</offsets></p><p><xref ref-type="bibr" rid="B42"><offsets xml_i="30445" xml_f="30447" txt_i="21008" txt_f="21010">42</offsets></xref><offsets xml_i="30454" xml_f="30554" txt_i="21010" txt_f="21110">], and the psychological problems associated with paralysis and pressure management in SCI victims [</offsets><xref ref-type="bibr" rid="B35"><offsets xml_i="30586" xml_f="30588" txt_i="21110" txt_f="21112">35</offsets></xref><offsets xml_i="30595" xml_f="30596" txt_i="21112" txt_f="21113">,</offsets><xref ref-type="bibr" rid="B43"><offsets xml_i="30628" xml_f="30630" txt_i="21113" txt_f="21115">43</offsets></xref><offsets xml_i="30637" xml_f="30638" txt_i="21115" txt_f="21116">,</offsets><xref ref-type="bibr" rid="B44"><offsets xml_i="30670" xml_f="30672" txt_i="21116" txt_f="21118">44</offsets></xref><offsets xml_i="30679" xml_f="30799" txt_i="21118" txt_f="21238">], it seems rational to shift to simpler methods that are more cost efficient and executable by the individual patient [</offsets><xref ref-type="bibr" rid="B31"><offsets xml_i="30831" xml_f="30833" txt_i="21238" txt_f="21240">31</offsets></xref><offsets xml_i="30840" xml_f="30841" txt_i="21240" txt_f="21241">,</offsets><xref ref-type="bibr" rid="B34"><offsets xml_i="30873" xml_f="30875" txt_i="21241" txt_f="21243">34</offsets></xref><offsets xml_i="30882" xml_f="30883" txt_i="21243" txt_f="21244">,</offsets><xref ref-type="bibr" rid="B35"><offsets xml_i="30915" xml_f="30917" txt_i="21244" txt_f="21246">35</offsets></xref><offsets xml_i="30924" xml_f="31058" txt_i="21246" txt_f="21380">]. HD treatment of pressure ulcers is less expensive and more comfortable and will ultimately increase the patients' self-confidence [</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="31089" xml_f="31090" txt_i="21380" txt_f="21381">8</offsets></xref><offsets xml_i="31097" xml_f="31098" txt_i="21381" txt_f="21382">,</offsets><xref ref-type="bibr" rid="B45"><offsets xml_i="31130" xml_f="31132" txt_i="21382" txt_f="21384">45</offsets></xref><offsets xml_i="31139" xml_f="31491" txt_i="21384" txt_f="21736">]. These adhesives are available in different sizes and brands convenient for use in ulcers of different parts of body. In the most recent products, the appropriate time for changing the adhesive is indicated by a color conversion. In addition, their transparency makes it easy to observe the ulcer's status without removing the adhesive and dressing [</offsets><xref ref-type="bibr" rid="B46"><offsets xml_i="31523" xml_f="31525" txt_i="21736" txt_f="21738">46</offsets></xref><offsets xml_i="31532" xml_f="31534" txt_i="21738" txt_f="21740">].</offsets></p><p><offsets xml_i="31541" xml_f="31938" txt_i="21741" txt_f="22135">Although the therapeutic effects of HD on sacral ulcers, in contrast to gluteal and ischial ulcers, did not appear in this survey to be significantly better (p &gt; 0.05) than phenytoin and simple dressings, nor was it less effective. Whether the lesser healing effect of HD on sacral ulcers corresponds to the pressure effects in this area, or to greater bacterial colonization or other factors [</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="31969" xml_f="31970" txt_i="22135" txt_f="22136">3</offsets></xref><offsets xml_i="31977" xml_f="31978" txt_i="22136" txt_f="22137">,</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="32009" xml_f="32010" txt_i="22137" txt_f="22138">4</offsets></xref><offsets xml_i="32017" xml_f="32018" txt_i="22138" txt_f="22139">,</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="32049" xml_f="32050" txt_i="22139" txt_f="22140">6</offsets></xref><offsets xml_i="32057" xml_f="32058" txt_i="22140" txt_f="22141">,</offsets><xref ref-type="bibr" rid="B47"><offsets xml_i="32090" xml_f="32092" txt_i="22141" txt_f="22143">47</offsets></xref><offsets xml_i="32099" xml_f="32143" txt_i="22143" txt_f="22187">], needs to be clarified by further studies.</offsets></p><p><offsets xml_i="32150" xml_f="33152" txt_i="22188" txt_f="23190">Gross differences among the three treatment modalities precluded double blinding. Blinding the authors to the treatment groups minimized this limitation. The major tasks, i.e. defining the study population, enrolling the participants who met the eligibility criteria and assessing the primary and secondary outcomes, were performed blind by the authors. To reduce differences in baseline demographic characteristics among the treatment groups and subgroups and to minimize losses to follow-up, war-related SCI patients were recruited and all the patients who met the eligibility criteria were enrolled in the study. They were all relatively young males (mean age 36.64 ± 6.04 years) and had good motivation to complete the course of treatment. The results of this trial cannot be extrapolated to stage III or stage IV pressure ulcers or to other types of wounds. Furthermore, the small numbers of gluteal and sacral ulcers preclude definitive statements about differences among the treatment subgroups.</offsets></p></sec><sec><title><offsets xml_i="33174" xml_f="33184" txt_i="23192" txt_f="23202">Conclusion</offsets></title><p><offsets xml_i="33195" xml_f="33350" txt_i="23203" txt_f="23358">The observed efficacy of HD in the treatment of pressure ulcers suggests that it might be effectively applied to other stage I or stage II pressure ulcers.</offsets></p></sec><sec><title><offsets xml_i="33372" xml_f="33391" txt_i="23360" txt_f="23379">Competing interests</offsets></title><p><offsets xml_i="33402" xml_f="33462" txt_i="23380" txt_f="23440">The author(s) declare that they have no competing interests.</offsets></p></sec><sec><title><offsets xml_i="33484" xml_f="33505" txt_i="23442" txt_f="23463">Authors contributions</offsets></title><p><offsets xml_i="33516" xml_f="33898" txt_i="23464" txt_f="23846">MTH designed the study and wrote the proposal, and visited all the patients and examined them for eligibility criteria. HKH designed the study, helped in the recruitment of patients, planned the data analyses, assessed the trial groups for primary and secondary outcomes and wrote the paper. FY reviewed the literature, advised on data analysis and contributed to writing the paper.</offsets></p></sec><sec><title><offsets xml_i="33920" xml_f="33927" txt_i="23848" txt_f="23855">Funding</offsets></title><p><offsets xml_i="33938" xml_f="34119" txt_i="23856" txt_f="24037">The study was supported by the Jaonbazan Medical and Engineering Research Center, the medical and research section of the official governmental body responsible for SCI war victims.</offsets></p></sec><sec><title><offsets xml_i="34141" xml_f="34164" txt_i="24039" txt_f="24062">Pre-publication history</offsets></title><p><offsets xml_i="34175" xml_f="34239" txt_i="24063" txt_f="24127">The pre-publication history for this paper can be accessed here:</offsets></p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-5945/4/18/prepub"></ext-link></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The authors sincerely thank Hassan Rafati, statistics and epidemiology MSc, Dr. Masood Ahmadzad Asl, for their excellent work on randomization and analysis of the data; Dr. Farhad Zargari, who kindly edited the English text of the paper; Dr. Seyed Mortezah Hosseini and Dr. Aghdas Aghaii, who administered the treatment protocols to the trial groups; Seyed Ali Salehi for his computer programming; the nursing staff of the internal medicine and rehabilitation wards of Baqyiatollah Hospital, who administered the interventions to patients; and Elham Mellat, who did the clerical work and typed the paper.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yarkony</surname><given-names>GM</given-names></name></person-group><article-title>Pressure ulcers: a review</article-title><source>Arch Phys Med Rehabil</source><year>1994</year><volume>75</volume><fpage>908</fpage><lpage>917</lpage><pub-id pub-id-type="pmid">8053799</pub-id><pub-id pub-id-type="doi">10.1016/0003-9993(94)90117-1</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>RR</given-names></name><name><surname>Meyer</surname><given-names>PR</given-names></name></person-group><article-title>Prevalence and incidence of pressure sores in acute spinal cord injuries</article-title><source>Paraplegia</source><year>1981</year><volume>19</volume><fpage>235</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">7290733</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>JS</given-names></name><name><surname>Burns</surname><given-names>PE</given-names></name></person-group><article-title>Pressure sores and the spinal cord injured</article-title><source>SCI Digest</source><year>1981</year><volume>3</volume><fpage>11</fpage><lpage>23</lpage></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>GP</given-names></name><name><surname>Garber</surname><given-names>SL</given-names></name></person-group><article-title>Prospective study of pressure ulcer risk in spinal cord injury patients</article-title><source>Paraplegia</source><year>1994</year><volume>32</volume><fpage>150</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">8008417</pub-id></citation></ref><ref id="B5"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Whaton</surname><given-names>GW</given-names></name><name><surname>Milani</surname><given-names>JC</given-names></name><name><surname>Dean</surname><given-names>LS</given-names></name></person-group><article-title>Pressure sore profile: cost and management</article-title><source>ASIA Abstracts Digest</source><year>1987</year><fpage>115</fpage><lpage>119</lpage></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garber</surname><given-names>SL</given-names></name><name><surname>Rintala</surname><given-names>DH</given-names></name><name><surname>Rossi</surname><given-names>CD</given-names></name><name><surname>Hart</surname><given-names>KA</given-names></name><name><surname>Fuhrer</surname><given-names>MJ</given-names></name></person-group><article-title>Reported pressure ulcer prevention and management techniques by person with spinal cord injury</article-title><source>Arch Phys Med Rehabil</source><year>1996</year><volume>77</volume><fpage>744</fpage><lpage>749</lpage><pub-id pub-id-type="pmid">8702366</pub-id><pub-id pub-id-type="doi">10.1016/S0003-9993(96)90251-8</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nussbaum</surname><given-names>EL</given-names></name><name><surname>Biemann</surname><given-names>I</given-names></name><name><surname>Mustard</surname><given-names>B</given-names></name></person-group><article-title>Comparison of ultrasound /ultraviolet-C and laser for treatment of pressure ulcers in patient with spinal cord injury</article-title><source>Phys Ther</source><year>1994</year><volume>74</volume><fpage>812</fpage><lpage>825</lpage><pub-id pub-id-type="pmid">8066108</pub-id></citation></ref><ref id="B8"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Harding</surname><given-names>K</given-names></name><name><surname>Cutting</surname><given-names>K</given-names></name><name><surname>Price</surname><given-names>P</given-names></name></person-group><article-title>The cost-effectiveness of wound management protocols of care</article-title><source>Br J Nurs</source><year>2000</year><fpage>6</fpage><lpage>24</lpage></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Basta</surname><given-names>SM</given-names></name></person-group><article-title>Pressure sore prevention education with the spinal cord injured</article-title><source>Rehabil Nurs</source><year>1991</year><volume>16</volume><fpage>6</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1989050</pub-id></citation></ref><ref id="B10"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Ozer</surname><given-names>MN</given-names></name><name><surname>Lappin</surname><given-names>C</given-names></name><name><surname>Countney</surname><given-names>J</given-names></name><name><surname>Hussey</surname><given-names>RW</given-names></name></person-group><article-title>Skin care program: Efficacy of patient participation</article-title><source>Abstracts Digest of the Fifteenth Annual Meeting of the American Spinal Injury Association</source><year>1989</year><publisher-name>Atlanta (GA): American Spinal Injury Association</publisher-name><fpage>129</fpage></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yarkony</surname><given-names>GM</given-names></name><name><surname>Roth</surname><given-names>EJ</given-names></name><name><surname>Cybulski</surname><given-names>GR</given-names></name><name><surname>Jaeger</surname><given-names>RJ</given-names></name></person-group><article-title>Neuromuscular stimulation in spinal cord injury II: prevention of secondary complications</article-title><source>Arch Phys Med Rehabil</source><year>1992</year><volume>73</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">1543418</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Witkowski</surname><given-names>JA</given-names></name><name><surname>Parish</surname><given-names>LC</given-names></name></person-group><article-title>Debridement of cutaneous ulcers: medical and surgical aspects</article-title><source>Clin Dermatol</source><year>1992</year><volume>9</volume><fpage>585</fpage><lpage>591</lpage><pub-id pub-id-type="pmid">1822415</pub-id><pub-id pub-id-type="doi">10.1016/0738-081X(91)90088-3</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yarkony</surname><given-names>GM</given-names></name><name><surname>Kramer</surname><given-names>E</given-names></name><name><surname>King</surname><given-names>R</given-names></name><name><surname>Lukanc</surname><given-names>C</given-names></name><name><surname>Carle</surname><given-names>TV</given-names></name></person-group><article-title>Pressure sore management: Efficacy of a moisture reactive occlusive dressing</article-title><source>Arch Phys Med Rehabil</source><year>1984</year><volume>65</volume><fpage>597</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">6487064</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gorse</surname><given-names>GT</given-names></name><name><surname>Messner</surname><given-names>RL</given-names></name></person-group><article-title>Improved pressure sore healing with hydrocolloid dressings</article-title><source>Arch Dermatol</source><year>1987</year><volume>123</volume><fpage>766</fpage><lpage>771</lpage><pub-id pub-id-type="pmid">3555355</pub-id><pub-id pub-id-type="doi">10.1001/archderm.123.6.766</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falanga</surname><given-names>V</given-names></name></person-group><article-title>Occlusive wound dressings: why when which?</article-title><source>Arch Dermatol</source><year>1988</year><volume>124</volume><fpage>872</fpage><lpage>877</lpage><pub-id pub-id-type="pmid">3288123</pub-id><pub-id pub-id-type="doi">10.1001/archderm.124.6.872</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xakellis</surname><given-names>GL</given-names></name><name><surname>Chrischilles</surname><given-names>EA</given-names></name></person-group><article-title>Hydrocolloid vs saline – gauze dressings in treating pressure ulcers: a cost – effectiveness analysis</article-title><source>Arch Phys Med Rehabil</source><year>1992</year><volume>73</volume><fpage>463</fpage><lpage>469</lpage><pub-id pub-id-type="pmid">1580775</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fowler</surname><given-names>E</given-names></name><name><surname>Papen</surname><given-names>JC</given-names></name></person-group><article-title>Evaluation of an alginate dressing for pressure ulcers</article-title><source>Decubitus</source><year>1991</year><volume>4</volume><fpage>47</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">1872977</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chapius</surname><given-names>A</given-names></name><name><surname>Dollfus</surname><given-names>P</given-names></name></person-group><article-title>The use of calcium alginate dressings in the management of decubitus ulcers in patients with spinal cord lesions</article-title><source>Paraplegia</source><year>1990</year><volume>28</volume><fpage>269</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">2235034</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lineaweaver</surname><given-names>W</given-names></name><name><surname>Howard</surname><given-names>R</given-names></name><name><surname>Soucy</surname><given-names>D</given-names></name><name><surname>McMorris</surname><given-names>S</given-names></name><name><surname>Freeman</surname><given-names>J</given-names></name><name><surname>Crain</surname><given-names>C</given-names></name><name><surname>Robertson</surname><given-names>J</given-names></name><name><surname>Rumley</surname><given-names>T</given-names></name></person-group><article-title>Topical antimicrobial toxicity</article-title><source>Arch Surg</source><year>1985</year><volume>120</volume><fpage>267</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">3970664</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shea</surname><given-names>JD</given-names></name></person-group><article-title>Pressure sores: classification and management</article-title><source>Clin Orthop</source><year>1975</year><volume>112</volume><fpage>89</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">1192654</pub-id></citation></ref><ref id="B21"><citation citation-type="other"><person-group person-group-type="author"><collab>National Pressure Ulcer Advisory Panel</collab></person-group><article-title>Pressure ulcers: incidence, economics, risk assessment</article-title><source>Consensus Development Conference Statement West Dundee, Illinois, S- N Publications Incorporated</source><year>1989</year></citation></ref><ref id="B22"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Compbell</surname><given-names>MJ</given-names></name><name><surname>Machin</surname><given-names>D</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Campbell MJ, Machin D</surname></name></person-group><article-title>The randomized controlled trial</article-title><source>In Medical Statistics, a commonsense approach</source><year>1999</year><edition>3</edition><publisher-name>Chichester: John Wiley &amp; Sons</publisher-name><fpage>119</fpage></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bender</surname><given-names>R</given-names></name></person-group><article-title>Calculating confidence interval for number to treat</article-title><source>Control Clin Trial</source><year>2001</year><volume>22</volume><fpage>102</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/S0197-2456(00)00134-3</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>M</given-names></name></person-group><article-title>Acceleration of gingival woundhealing in nonepileptic patients recieving diphenyl hydantoin sodium</article-title><source>Exp Med Surg</source><year>1958</year><volume>16</volume><fpage>41</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">13537920</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Modaghegh</surname><given-names>S</given-names></name><name><surname>Salehian</surname><given-names>B</given-names></name><name><surname>Tawassoli</surname><given-names>M</given-names></name><name><surname>Djamshidi</surname><given-names>A</given-names></name><name><surname>Sheikh Rezai</surname><given-names>A</given-names></name></person-group><article-title>Use of phenytoin in healing of war and non-war wounds: A pilot study of 25 cases</article-title><source>Int J Dermatol</source><year>1989</year><volume>28</volume><fpage>347</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">2666326</pub-id></citation></ref><ref id="B26"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Elmzayat</surname><given-names>SG</given-names></name></person-group><article-title>Effectiveness of topical phenytoin in war-related missile wounds and decubitus ulcers</article-title><source>presented to the 10th annual meeting of American Academy of Neurological and Orthopedic Surgeons Las Vegas</source><year>1986</year></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shafer</surname><given-names>WG</given-names></name><name><surname>Beatty</surname><given-names>RE</given-names></name><name><surname>Davis</surname><given-names>WB</given-names></name></person-group><article-title>Effect of dilantin sodium on tensile strength of healing wounds</article-title><source>Proc Soc Exp Biol Med</source><year>1958</year><volume>98</volume><fpage>348</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">13554642</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kelin</surname><given-names>EE</given-names></name><name><surname>Gorling</surname><given-names>RJ</given-names></name></person-group><article-title>Healing qualities of an epilepsy drug</article-title><source>Dental Prog</source><year>1961</year><volume>l</volume><fpage>126</fpage><lpage>9</lpage></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hutchinson</surname><given-names>JJ</given-names></name><name><surname>Mc Guckin</surname><given-names>M</given-names></name></person-group><article-title>Occlusive dressings: a microbiologic and clinical review</article-title><source>Am J Infect Control</source><year>1990</year><volume>18</volume><fpage>257</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">2206087</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Annoni</surname><given-names>F</given-names></name><name><surname>Rosina</surname><given-names>M</given-names></name><name><surname>Chiurazzi</surname><given-names>D</given-names></name><name><surname>Ceva</surname><given-names>M</given-names></name></person-group><article-title>The effect of a hydrocolloid dressing on bacterial growth and the healing process of leg ulcers</article-title><source>Int Angiol</source><year>1989</year><volume>8</volume><fpage>224</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">2634718</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eisenbud</surname><given-names>D</given-names></name><name><surname>Hunter</surname><given-names>H</given-names></name><name><surname>Kessler</surname><given-names>L</given-names></name><name><surname>Zulkowski</surname><given-names>K</given-names></name></person-group><article-title>Hydrogel wound dressings: where do we stand in 2003?</article-title><source>Ostomy Wound Manage</source><year>2003</year><volume>49</volume><fpage>52</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">14652421</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>KW</given-names></name><name><surname>Alsagof</surname><given-names>S</given-names></name><name><surname>Ong</surname><given-names>KT</given-names></name><name><surname>Sim</surname><given-names>PH</given-names></name></person-group><article-title>Pressure ulcer: randomized controlled trial comparing hydrocolloid and saline gauze dressings</article-title><source>Med J Malaysia</source><year>1998</year><volume>53</volume><fpage>428</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">10971989</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wynne</surname><given-names>R</given-names></name><name><surname>Botti</surname><given-names>M</given-names></name><name><surname>Stedman</surname><given-names>H</given-names></name><name><surname>Holsworth</surname><given-names>L</given-names></name><name><surname>Harinos</surname><given-names>M</given-names></name><name><surname>Flavell</surname><given-names>O</given-names></name><name><surname>Manterfield</surname><given-names>C</given-names></name></person-group><article-title>Effect of three wound dressings on infection, healing comfort and cost in patients with sternotomy wounds: a randomized trial</article-title><source>Chest</source><year>2004</year><volume>125</volume><fpage>43</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">14718419</pub-id><pub-id pub-id-type="doi">10.1378/chest.125.1.43</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>C</given-names></name></person-group><article-title>3M Tegasirb Thin: a hydrocolloid dressing for chronic wounds</article-title><source>Br J Nurs</source><year>2000</year><volume>9</volume><fpage>720</fpage><lpage>723</lpage><pub-id pub-id-type="pmid">11235265</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>YC</given-names></name><name><surname>Shin</surname><given-names>JC</given-names></name><name><surname>Park</surname><given-names>CI</given-names></name><name><surname>Oh</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>YS</given-names></name></person-group><article-title>Efficacy of Hydrocolloid Occlusive Dressing Technique in Decubitus Ulcer Treatment: A comparative study</article-title><source>Yonsei Med J</source><year>1996</year><volume>37</volume><fpage>181</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">8826783</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reuterving</surname><given-names>CO</given-names></name><name><surname>Agren</surname><given-names>MS</given-names></name><name><surname>Soderberg</surname><given-names>TA</given-names></name><name><surname>Tengrup</surname><given-names>I</given-names></name><name><surname>Hallmans</surname><given-names>G</given-names></name></person-group><article-title>The effects of occlusive dressings on inflammation and granulation tissue formation in excised wounds in rats</article-title><source>Scand J Plast Recontr Surg Hand Surg</source><year>1989</year><volume>23</volume><fpage>89</fpage><lpage>96</lpage></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alm</surname><given-names>A</given-names></name><name><surname>Hornmark</surname><given-names>A</given-names></name><name><surname>Fall</surname><given-names>P</given-names></name><name><surname>Linder</surname><given-names>L</given-names></name><name><surname>Bergstrand</surname><given-names>B</given-names></name><name><surname>Ehrnebo</surname><given-names>M</given-names></name><name><surname>Madsen</surname><given-names>SM</given-names></name><name><surname>Setterberg</surname><given-names>G</given-names></name></person-group><article-title>Care of pressure sores: a controlled study of the use of a hydrocolloid dressing compared with a wet saline gauze compresses</article-title><source>Acta Derm Venereol</source><year>1989</year><volume>149</volume><fpage>1</fpage><lpage>10</lpage></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>A</given-names></name></person-group><article-title>Managing sacral pressure ulcers with hydrocolloid dressing: results of a controlled clinical study</article-title><source>Ostomy Wound Man</source><year>1995</year><volume>41</volume><fpage>52</fpage><lpage>64</lpage></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russel</surname><given-names>L</given-names></name></person-group><article-title>Understanding physiology of wound healing and how dressings help</article-title><source>Br J Nurs</source><year>2000</year><volume>9</volume><fpage>10</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">10887841</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matzen</surname><given-names>S</given-names></name><name><surname>Perchardt</surname><given-names>A</given-names></name><name><surname>Alsbjorn</surname><given-names>B</given-names></name></person-group><article-title>A new amorphous hydrocolloid for the treatment of pressure sores: a randomized, controlled study</article-title><source>Scand J Plast Reconstr Surg Hand Surg</source><year>1999</year><volume>33</volume><fpage>13</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">10207960</pub-id><pub-id pub-id-type="doi">10.1080/02844319950159578</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>D</given-names></name><name><surname>Goode</surname><given-names>PS</given-names></name><name><surname>La Master</surname><given-names>K</given-names></name><name><surname>Tennyson</surname><given-names>T</given-names></name></person-group><article-title>Acemannan hydrogel dressing versus saline dressing for pressure ulcers: A randomized, controlled trial</article-title><source>Adv Wound Care</source><year>1998</year><volume>11</volume><fpage>273</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">10326343</pub-id></citation></ref><ref id="B42"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Wharton</surname><given-names>GW</given-names></name><name><surname>Milani</surname><given-names>JC</given-names></name><name><surname>Dean</surname><given-names>LS</given-names></name></person-group><article-title>Pressure sore profile: Cost and management</article-title><source>ASIA Abstracts Digest</source><year>1987</year><fpage>115</fpage><lpage>119</lpage></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>L</given-names></name></person-group><article-title>Perceptions of pressure ulcers among young men with spinal injury</article-title><source>Br J Community Nurs</source><year>2002</year><volume>7</volume><fpage>451</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">12362141</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harding-Okimoto</surname><given-names>MB</given-names></name></person-group><article-title>Pressure ulcers, self-concept and body image in spinal cord injury patients</article-title><source>SCI Nurs</source><year>1997</year><volume>14</volume><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">9510832</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kown Lee</surname><given-names>S</given-names></name><name><surname>Turnbull</surname><given-names>GB</given-names></name></person-group><article-title>Wound care: what's really cost-effective?</article-title><source>Nursing Homes</source><year>2001</year><volume>50</volume><fpage>40</fpage><lpage>44</lpage></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goodhead</surname><given-names>A</given-names></name></person-group><article-title>Clinical efficacy of Comfeel Plus Transparant Dressing</article-title><source>Br J Nurs</source><year>2002</year><volume>11</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">11873220</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crenshaw</surname><given-names>RP</given-names></name><name><surname>Vistnes</surname><given-names>LM</given-names></name></person-group><article-title>A decade of pressure sore research: 1977–1987</article-title><source>J Rehabil Res Dev</source><year>1989</year><volume>26</volume><fpage>63</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">2645399</pub-id></citation></ref></ref-list></back></article>